| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_894b493fea374e8188851ac59a3ea043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2aad2628015c1bb5de7de0ab8d0290a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_063b65d5f50fdc43f5d3c006f3fd43e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2738f7fce3a38a4de0acbee7238c306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10f1d65a4768dc43ae76fb7916ed00bb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
| filingDate |
2013-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47f66a5cb1a265f7562175772528b2f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_868198544011ae4e8ead23f35ba29122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1eb23d3e3c5587e0aad0415855151ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6a040abfeea41315919906bcf14894b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b47361caf756a4dcc3c05f472e4c859e |
| publicationDate |
2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014093516-A1 |
| titleOfInvention |
Human antibodies that bind the p40 subunit of human il-12/il-23 and uses therefor |
| abstract |
The invention provides human antibodies that bind to the p40 subunit of human IL-12 and/or IL-23. The invention further provides a method of treating psoriasis in a subject by administering to a subject an antibody that binds to the p40 subunit of IL-12 and/or IL-23. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9051368-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8945545-B2 |
| priorityDate |
2008-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |